DRKS00022043已完成不适用
Effectiveness of Ustekinumab in Induction and Maintenance Therapy of ulcerative colitis (RUN-UC) - RUN-UC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 507
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Patients who, according to the doctor's decision, are to be treated with Ustekinumab or another biologic or Tofacitinib.
- •- Ulcerative colitis patients between the ages of 18 and 80 at inclusion.
- •- In-label use according to the summary of product characteristics of the respective medication.
排除标准
- •Planned surgical intervention with hospitalization.
- •- Malignant disease in history (except Non-Melanoma Skin Cancer).
- •- All contraindications according to the summary of product characteristics of the respective medication.
研究者
相似试验
已完成
不适用
Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s DiseaseK50Crohn disease [regional enteritis]DRKS00011811CED Service GmbH901
招募中
不适用
Prospective evaluation of ustekinumab(UST)- effects in patients with ulcerative colitisulcerative colitisJPRN-UMIN000039946Saitama Medical Ctnter, Saitama Medical University35
已完成
4 期
Mechanism of action study of Ustekinumab treatment in psoriatic arthritis: Impact on cellular and molecular pathways of synovial inflammation and tissue remodelingpsoriatic arthropathy1000381610023213psoriatic arthritisNL-OMON47065Academisch Medisch Centrum16
进行中（未招募）
不适用
Mechanism of action study of Ustekinumab treatment in psoriatic arthritispsoriatic arthritisMedDRA version: 17.1Level: LLTClassification code 10066579Term: Progression of psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10066730Term: Recurrent psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10003377Term: Arthropathy psoriaticSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10037161Term: Psoriatic arthritis aggravatedSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: PTClassification code 10037162Term: Psoriatic arthropathySystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: HLTClassification code 10037163Term: Psoriatic arthropathiesSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 17.1Level: LLTClassification code 10037166Term: Psoriatic spondylitisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2014-003148-11-NLAcademic Medical Center
招募中
不适用
Effectiveness and Safety of Ustekinumab Intensification in Crohn's DiseaseCrohn DiseaseNCT05705856Second Affiliated Hospital, School of Medicine, Zhejiang University200